Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abul K Abbas

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Clinical Immunology (Orlando, Fla.)|September 10, 2011
A network of regulatory pathways in lepromatous leprosyAbul K Abbas
Autoimmunity Reviews|July 10, 2003
The control of T cell activation vs. toleranceAbul K Abbas
Transactions of the American Clinical and Climatological Association|September 14, 2019
HARNESSING THE IMMUNE RESPONSE: BASIC PRINCIPLES AND THERAPEUTIC APPLICATIONSAbul K Abbas
The American Journal of Pathology|August 24, 2020
The Surprising Story of IL-2: From Experimental Models to Clinical ApplicationAbul K Abbas
Annual Review of Pathology|January 24, 2024
Chance and Opportunity: A Personal StoryAbul K Abbas
Nature Immunology|September 3, 2002
Life and death in effector T cellsHans Dooms, Abul K Abbas
Immunological Reviews|July 11, 2006
Control of CD4+ T-cell memory by cytokines and costimulatorsHans Dooms, Abul K Abbas
Nature Reviews. Immunology|April 18, 2015
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseasesDavid Klatzmann, Abul K Abbas
European Journal of Immunology|May 12, 2010
Revisiting the role of IL-2 in autoimmunityHans Dooms, Abul K Abbas
Immunity|June 24, 2003
The activation of lymphocytes is in their CARMAAbul K Abbas, Ranjan Sen
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Clinical Immunology (Orlando, Fla.)|September 10, 2011
A network of regulatory pathways in lepromatous leprosyAbul K Abbas
Autoimmunity Reviews|July 10, 2003
The control of T cell activation vs. toleranceAbul K Abbas
Transactions of the American Clinical and Climatological Association|September 14, 2019
HARNESSING THE IMMUNE RESPONSE: BASIC PRINCIPLES AND THERAPEUTIC APPLICATIONSAbul K Abbas
The American Journal of Pathology|August 24, 2020
The Surprising Story of IL-2: From Experimental Models to Clinical ApplicationAbul K Abbas
Annual Review of Pathology|January 24, 2024
Chance and Opportunity: A Personal StoryAbul K Abbas
Nature Immunology|September 3, 2002
Life and death in effector T cellsHans Dooms, Abul K Abbas
Immunological Reviews|July 11, 2006
Control of CD4+ T-cell memory by cytokines and costimulatorsHans Dooms, Abul K Abbas
Nature Reviews. Immunology|April 18, 2015
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseasesDavid Klatzmann, Abul K Abbas
European Journal of Immunology|May 12, 2010
Revisiting the role of IL-2 in autoimmunityHans Dooms, Abul K Abbas
Immunity|June 24, 2003
The activation of lymphocytes is in their CARMAAbul K Abbas, Ranjan Sen
Pageof 8